OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 6 citing articles:

Dendritic cells: the yin and yang in disease progression
Carlos Jiménez‐Cortegana, Francisca Palomares, Gonzalo Álba, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5

Comprehensive Pan-cancer Analysis Revealed CASP10 As a Promising Biomarker For Diverse Tumor Types
Qian Wang, Yaping Jiang, Weijia Liao, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access

Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies
Marcus Bauer, C. Schöbel, Claudia Wickenhauser, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Bioinformatics analysis of an immunotherapy responsiveness- related gene signature in predicting lung adenocarcinoma prognosis
Yupeng Jiang, Bacha Hammad, Hong Huang, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 6, pp. 1277-1295
Open Access | Times Cited: 1

DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation
Nanbin Liu, Qian Wang, Peng‐Peng Zhu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 20, pp. 6594-6615
Open Access | Times Cited: 1

Clinical and Prognostic Implications of an Alternative Splicing-related Risk Model Based on TP53 Status in Breast Cancer
Xinrui Wang, Zhoujie Ye, Liping Zhou, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 26, Iss. 2, pp. 246-259
Closed Access

Page 1

Scroll to top